Characterization of Antimicrobial Peptides toward the Development of Novel Antibiotics.
about
Insights into the antimicrobial properties of hepcidins: advantages and drawbacks as potential therapeutic agentsEfficacy of the antimicrobial peptide TP4 against Helicobacter pylori infection: in vitro membrane perturbation via micellization and in vivo suppression of host immune responses in a mouse modelCandidacidal Activity of Selected Ceragenins and Human Cathelicidin LL-37 in Experimental Settings Mimicking Infection Sites.Design and activity of a cyclic mini-β-defensin analog: a novel antimicrobial tool.Characterization of Two Antimicrobial Peptides from Antarctic Fishes (Notothenia coriiceps and Parachaenichthys charcoti).Novel synthetic analogues of avian β-defensin-12: the role of charge, hydrophobicity, and disulfide bridges in biological functions.Cm-p5: an antifungal hydrophilic peptide derived from the coastal mollusk Cenchritis muricatus (Gastropoda: Littorinidae)Short, Synthetic Cationic Peptides Have Antibacterial Activity against Mycobacterium smegmatis by Forming Pores in Membrane and Synergizing with Antibiotics.The Antimicrobial Peptides P-113Du and P-113Tri Function against Candida albicans.Therapeutic Potential of Gramicidin S in the Treatment of Root Canal Infections.Antimicrobial Protection of Marsupial Pouch Young.Novel anti-Helicobacter pylori therapies.Antimicrobial peptides: therapeutic potentials.Designing drugs that overcome antibacterial resistance: where do we stand and what should we do?Antimicrobial peptides (AMPs) as drug candidates: a patent review (2003-2015).The therapeutic applications of antimicrobial peptides (AMPs): a patent review.β-Boomerang Antimicrobial and Antiendotoxic Peptides: Lipidation and Disulfide Bond Effects on Activity and Structure.Synthetic antimicrobial and LPS-neutralising peptides suppress inflammatory and immune responses in skin cells and promote keratinocyte migration.Chitosan nanoparticles loaded with the antimicrobial peptide temporin B exert a long-term antibacterial activity in vitro against clinical isolates of Staphylococcus epidermidis.Multivalent gold nanoparticle-peptide conjugates for targeting intracellular bacterial infections.Bacteria-Assisted Activation of Antimicrobial Polypeptides by a Random-Coil to Helix Transition.From amino acids polymers, antimicrobial peptides, and histones, to their possible role in the pathogenesis of septic shock: a historical perspective.In vitro potential of Lycosin-I as an alternative antimicrobial drug for treatment of multidrug-resistant Acinetobacter baumannii infections.Development of novel ultrashort antimicrobial peptide nanoparticles with potent antimicrobial and antibiofilm activities against multidrug-resistant bacteria.Characterization of the antimicrobial peptide family defensins in the Tasmanian devil (Sarcophilus harrisii), koala (Phascolarctos cinereus), and tammar wallaby (Macropus eugenii).Biosynthesis of 2-aminooctanoic acid and its use to terminally modify a lactoferricin B peptide derivative for improved antimicrobial activity.Design, Recombinant Fusion Expression and Biological Evaluation of Vasoactive Intestinal Peptide Analogue as Novel Antimicrobial Agent.Natural Antimicrobial Peptides as Inspiration for Design of a New Generation Antifungal Compounds.Development of peptide inhibitors of HIV transmission.Peptide dendrimers as "lead compounds" for the treatment of chronic lung infections by in cystic fibrosis patients: in vitro and in vivo studiesAntimicrobial Activity of NCR Plant Peptides Strongly Depends on the Test AssaysThe Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of to Antimicrobial PeptidesControl of Propionibacterium acnes by natural antimicrobial substances: Role of the bacteriocin AS-48 and lysozyme
P2860
Q26991996-9F90A03F-F53A-464F-9D8D-363EE65346BBQ35955162-872593CF-84A8-4D03-876A-95B13A35C0D7Q36055572-4C5F8A26-6DD0-4AB0-9076-81A524676B44Q36176823-861A6EC7-BA42-4540-B942-01750B8A27E0Q36259823-B96C0207-4805-48CA-B277-ED7E2D50D32DQ36288808-3779FECB-D32B-4DB4-8749-86F0AB21D61FQ36608221-BEA2C2BC-E47A-48C9-9BC5-D75899D691D5Q36683469-90F57CC6-7B49-4D80-A9EA-598FBA433B9EQ37287922-C72E73FE-BF47-462B-872B-070660B55986Q37290856-5C126B3E-A080-473F-8FAF-08270A4E0F32Q37683041-19F86E37-D5C9-4B9A-8D6E-D62EB2B82BAFQ38257748-AE00F612-1094-4BEE-8081-78C461CA50E7Q38265118-38219167-517E-44DD-9FDC-FCF9945A5668Q38485480-D26BDB27-9922-4ECA-AFBD-7D8DE54F1204Q38803962-73D25A0B-E8E2-4C18-AE2B-41D08E6601E1Q39062867-5B1E2DA8-7B6E-43B6-870A-59DCA6B49877Q39205415-A2855B00-0F55-491F-8833-5ADE6B7D84E8Q39503515-2C801C34-C299-46C1-A55C-BE630D699070Q40007773-704EE67D-D89A-4C62-B7DF-7EC965E7B014Q40049719-ACB24015-B328-4E6C-B607-251859F449E5Q40153879-59F70B6C-5BB6-48D1-BFBE-3F97FA67B853Q40331159-A90ABAFE-903C-4F04-82AC-B31755D90E0DQ41748766-1DAE7F69-880B-497A-958E-208B501DAF79Q44484590-0A8884B4-C775-4B54-96F4-1097D650850CQ46460554-93443CC7-0837-4896-9586-F92C9BC120E6Q47312014-C99E8165-7CDD-42A4-839F-54F6AC944AA5Q47405151-6AB3BF6D-61CF-4A87-93D1-331CE691B166Q48163141-DFC0FC0D-F567-41D5-B1F8-E5EA67DA5B7AQ55317261-C67911D4-0554-4058-A00D-59E97D6B4B27Q57815884-15C1D997-7564-4493-8771-541428B6B175Q58693719-CB618E53-5D11-489B-B958-4967577E2731Q58758986-E5FDD973-C33E-4FA5-92F5-C50824DB6A6AQ58799513-15416A04-4EA5-4A85-8900-58EC36C568C1
P2860
Characterization of Antimicrobial Peptides toward the Development of Novel Antibiotics.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Characterization of Antimicrobial Peptides toward the Development of Novel Antibiotics.
@en
type
label
Characterization of Antimicrobial Peptides toward the Development of Novel Antibiotics.
@en
prefLabel
Characterization of Antimicrobial Peptides toward the Development of Novel Antibiotics.
@en
P2860
P356
P1433
P1476
Characterization of Antimicrobial Peptides toward the Development of Novel Antibiotics.
@en
P2093
Mitsuyoshi Ueda
P2860
P304
P356
10.3390/PH6081055
P50
P577
2013-08-21T00:00:00Z